Cite
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen
MLA
Hiroyuki Miura, et al. “Current Status of Radioligand Therapy and Positron-Emission Tomography with Prostate-Specific Membrane Antigen.” Annals of Nuclear Medicine, vol. 34, no. 12, Nov. 2020, pp. 879–83. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f0f24a6cfeea9d264798e0fa52ed7813&authtype=sso&custid=ns315887.
APA
Hiroyuki Miura, Ichiei Kuji, Ryogo Minamimoto, Masayuki Inubushi, & Kimiteru Ito. (2020). Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen. Annals of Nuclear Medicine, 34(12), 879–883.
Chicago
Hiroyuki Miura, Ichiei Kuji, Ryogo Minamimoto, Masayuki Inubushi, and Kimiteru Ito. 2020. “Current Status of Radioligand Therapy and Positron-Emission Tomography with Prostate-Specific Membrane Antigen.” Annals of Nuclear Medicine 34 (12): 879–83. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f0f24a6cfeea9d264798e0fa52ed7813&authtype=sso&custid=ns315887.